Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

Latest Eagle Health Investments LP Stock Portfolio

Eagle Health Investments LP Performance:
2025 Q4: 19.5%YTD: 25.28%2024: 17.12%
Performance for 2025 Q4 is 19.5%, and YTD is 25.28%, and 2024 is 17.12%.

About Eagle Health Investments LP and 13F Hedge Fund Stock Holdings

On 2026-02-06, the fund reported it's updated stock portfolio. In the 13F Holdings report, Eagle Health Investments LP reported an equity portfolio of $455.1 Millions as of 31 Dec, 2025.

The top stock holdings of Eagle Health Investments LP are , , NTRA. The fund has invested 11.6% of it's portfolio in ARGENX SE and 9.9% of portfolio in ICON PLC.

The fund managers got completely rid off ULTRAGENYX PHARMACEUTICAL IN (RARE), ALNYLAM PHARMACEUTICALS INC (ALNY) and AKERO THERAPEUTICS INC (AKRO) stocks. They significantly reduced their stock positions in EXACT SCIENCES CORP (EXAS), ILLUMINA INC (ILMN) and INSMED INC (INSM). Eagle Health Investments LP opened new stock positions in TERNS PHARMACEUTICALS INC (TERN), KYMERA THERAPEUTICS INC (KYMR) and REVOLUTION MEDICINES INC (RVMD). The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS) and ICON PLC.

Eagle Health Investments LP Annual Return Estimates Vs S&P 500

Our best estimate is that Eagle Health Investments LP made a return of 19.5% in the last quarter. In trailing 12 months, it's portfolio return was 25.28%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
terns pharmaceuticals inc11,113,600
kymera therapeutics inc10,605,500
revolution medicines inc9,231,440
legend biotech corp8,884,090
atai beckley nv6,864,660
soleno therapeutics inc6,255,130
protagonist therapeutics inc5,004,580
uniqure nv4,911,560
New stocks bought by Eagle Health Investments LP

Additions

Ticker% Inc.
compass pathways plc62.42
icon plc35.33
fortrea hldgs inc23.24
Additions to existing portfolio by Eagle Health Investments LP

Reductions

Ticker% Reduced
exact sciences corp-45.47
illumina inc-28.27
insmed inc-22.35
argenx se-18.98
natera inc-10.02
Eagle Health Investments LP reduced stake in above stock

Sold off

Ticker$ Sold
ultragenyx pharmaceutical in-20,965,800
agios pharmaceuticals inc-9,883,670
akero therapeutics inc-10,749,500
alnylam pharmaceuticals inc-10,800,800
Eagle Health Investments LP got rid off the above stocks

Sector Distribution

Eagle Health Investments LP has about 71.5% of it's holdings in Healthcare sector.

Sector%
Healthcare71.5
Others28.5

Market Cap. Distribution

Eagle Health Investments LP has about 37.7% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP37.7
UNALLOCATED28.9
MID-CAP19.4
SMALL-CAP12.6
MICRO-CAP1.5

Stocks belong to which Index?

About 40.4% of the stocks held by Eagle Health Investments LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others59.6
RUSSELL 200033.2
S&P 5007.2
Top 5 Winners (%)%
fortrea hldgs inc
86.4 %
EXAS
exact sciences corp
66.2 %
GH
guardant health inc
63.5 %
BBIO
bridgebio pharma inc
47.3 %
NTRA
natera inc
40.2 %
Top 5 Winners ($)$
NTRA
natera inc
13.2 M
GH
guardant health inc
11.3 M
ILMN
illumina inc
10.0 M
EXAS
exact sciences corp
9.8 M
fortrea hldgs inc
9.7 M
Top 5 Losers (%)%
PRCT
procept biorobotics corp
-11.8 %
ALKS
alkermes plc
-6.7 %
IMCR
immunocore hldgs plc
-4.5 %
Top 5 Losers ($)$
PRCT
procept biorobotics corp
-1.3 M
ALKS
alkermes plc
-0.2 M
IMCR
immunocore hldgs plc
-0.1 M

Eagle Health Investments LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Eagle Health Investments LP

Eagle Health Investments LP has 30 stocks in it's portfolio. About 70.7% of the portfolio is in top 10 stocks. PRCT proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Eagle Health Investments LP last quarter.

Last Reported on: 06 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions